Cargando…

Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study

BACKGROUND: Quality of life among prostate cancer survivors varies by socio-demographic factors and treatment type received; however, less in known about differences in functional outcomes by method of presentation. We investigate differences in reported urinary, bowel, sexual and hormone-related pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donnelly, David W., Vis, Linda C., Kearney, Therese, Sharp, Linda, Bennett, Damien, Wilding, Sarah, Downing, Amy, Wright, Penny, Watson, Eila, Wagland, Richard, Cross, William R., Mason, Malcolm D., Siesling, Sabine, van Manen, Jeannette G., Glaser, Adam W., Gavin, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792209/ https://www.ncbi.nlm.nih.gov/pubmed/31615476 http://dx.doi.org/10.1186/s12885-019-6164-5

Ejemplares similares

Factors influencing job loss and early retirement in working men with prostate cancer—findings from the population-based Life After Prostate Cancer Diagnosis (LAPCD) study
por: Bennett, Damien, et al.
Publicado: (2018)

Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy
por: Wilding, Sarah, et al.
Publicado: (2019)

Decision regret in men living with and beyond nonmetastatic prostate cancer in the United Kingdom: A population‐based patient‐reported outcome study
por: Wilding, Sarah, et al.
Publicado: (2020)

Urinary, bowel and sexual health in older men from Northern Ireland
por: Donnelly, David W., et al.
Publicado: (2018)

Stability of health-related quality of life and morbidity burden from 18 months after diagnosis of prostate cancer: results of a UK-wide population-based outcome cohort
por: Mason, Samantha J., et al.
Publicado: (2021)

Ethnicity and the prostate cancer experience: a qualitative metasynthesis
por: Rivas, Carol, et al.
Publicado: (2016)

Life after prostate cancer diagnosis: protocol for a UK-wide patient-reported outcomes study
por: Downing, Amy, et al.
Publicado: (2016)

The experiences and needs of couples affected by prostate cancer aged 65 and under: a qualitative study
por: Collaço, Nicole, et al.
Publicado: (2020)

Using the Framework Method for the Analysis of Qualitative Dyadic Data in Health Research
por: Collaço, Nicole, et al.
Publicado: (2021)

The PSA testing dilemma: GPs' reports of consultations with asymptomatic men: a qualitative study
por: Clements, Alison, et al.
Publicado: (2007)

Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners
por: Drummond, Frances J, et al.
Publicado: (2009)

PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK
por: Brett, Jo, et al.
Publicado: (2005)

Prostate Cancer Development Is Not Affected by Statin Use in Patients with Elevated PSA Levels
por: Meijer, Dennie, et al.
Publicado: (2019)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
por: Höti, Naseruddin, et al.
Publicado: (2023)

Temperature Control of psaA Expression by PsaE and PsaF in Yersinia pestis
por: Quinn, Joshua D., et al.
Publicado: (2019)

Evaluating patient‐reported outcome measures (PROMs) for bladder cancer: a systematic review using the COnsensus‐based Standards for the selection of health Measurement INstruments (COSMIN) checklist
por: Mason, Samantha J., et al.
Publicado: (2018)

Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients
por: Merriel, Samuel W. D., et al.
Publicado: (2022)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
por: Chang, Tsung-Hsin, et al.
Publicado: (2020)

Differences in experiences of care between patients diagnosed with metastatic cancer of known and unknown primaries: mixed-method findings from the 2013 cancer patient experience survey in England
por: Wagland, Richard, et al.
Publicado: (2017)

Life and bladder cancer: protocol for a longitudinal and cross-sectional patient-reported outcomes study of Yorkshire (UK) patients
por: Mason, Samantha J, et al.
Publicado: (2019)

Identification of PsA phenotypes with machine learning analytics using data from two phase III clinical trials of guselkumab in a bio-naïve population of patients with PsA
por: Richette, Pascal, et al.
Publicado: (2023)

The Relationship between Prostate Biopsy Results and PSA and Free PSA Ratio Changes in Elevated Serum PSA Patients with and without Antibiotherapy
por: Duran, Mesut Berkan, et al.
Publicado: (2020)

Prognostic significance of a novel indicator (PSA(postd3)/PSA(pre)) for PSA recurrence in patients after radical prostatectomy
por: Zhou, Zhien, et al.
Publicado: (2019)

Raising cut-off value of prostate specific antigen (PSA) for biopsy in symptomatic men in India to reduce unnecessary biopsy
por: Agnihotri, Shalini, et al.
Publicado: (2014)

Relationship between initial PSA density with future PSA kinetics and repeat biopsies in men with prostate cancer on active surveillance
por: Kotb, A F, et al.
Publicado: (2011)

Health-related quality of life after treatment for bladder cancer in England
por: Mason, Samantha J, et al.
Publicado: (2018)

Symptomatic Epilepsy
por: Sharp, Edward Affleck
Publicado: (1913)

Establishment of reference intervals for serum [−2]proPSA (p2PSA), %p2PSA and prostate health index in healthy men
por: Wu, Zhi-Yu, et al.
Publicado: (2019)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
por: Strittmatter, F, et al.
Publicado: (2011)

A Comparative Performance Analysis of Total PSA, Percentage Free PSA, PSA Velocity, and PSA Density versus the Detection of Primary Circulating Prostate Cells in Predicting Initial Prostate Biopsy Findings in Chilean Men
por: Murray, Nigel P., et al.
Publicado: (2014)

Effect of investigation intensity and treatment differences on prostate cancer survivor's physical symptoms, psychological well-being and health-related quality of life: a two country cross-sectional study
por: Gavin, Anna T, et al.
Publicado: (2016)

Qualitative analysis of patients’ feedback from a PROMs survey of cancer patients in England
por: Corner, Jessica, et al.
Publicado: (2013)

Identification of the main malaria vectors in the Anopheles gambiae species complex using a TaqMan real-time PCR assay
por: Bass, Chris, et al.
Publicado: (2007)

PSA screening – for whom and when?
por: Albers, Peter
Publicado: (2019)

Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis
por: van Maaren, Marissa C., et al.
Publicado: (2021)

Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA.
por: Nilsson, O., et al.
Publicado: (1997)

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
por: Tomioka, Atsushi, et al.
Publicado: (2014)

Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer
por: Burchardt, Wojciech, et al.
Publicado: (2018)

Assessment of the many faces of PsA: single and composite measures in PsA clinical trials
por: McGagh, Dylan, et al.
Publicado: (2020)

The performance of FIT-based and other risk prediction models for colorectal neoplasia in symptomatic patients: a systematic review
por: Hampton, James S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8v75v4cp9038ik6l13mi751nvb